JP2023548467A5 - - Google Patents
Info
- Publication number
- JP2023548467A5 JP2023548467A5 JP2023526068A JP2023526068A JP2023548467A5 JP 2023548467 A5 JP2023548467 A5 JP 2023548467A5 JP 2023526068 A JP2023526068 A JP 2023526068A JP 2023526068 A JP2023526068 A JP 2023526068A JP 2023548467 A5 JP2023548467 A5 JP 2023548467A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- cell
- receptor
- car
- population
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063109828P | 2020-11-04 | 2020-11-04 | |
| US63/109,828 | 2020-11-04 | ||
| PCT/US2021/058118 WO2022098914A1 (en) | 2020-11-04 | 2021-11-04 | Engineered ipsc and persistent immune effector cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023548467A JP2023548467A (ja) | 2023-11-17 |
| JP2023548467A5 true JP2023548467A5 (cg-RX-API-DMAC10.html) | 2024-11-13 |
Family
ID=81457363
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023526068A Pending JP2023548467A (ja) | 2020-11-04 | 2021-11-04 | 操作されたiPSC及び持続性免疫エフェクター細胞 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230390337A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4240831A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2023548467A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20230098649A (cg-RX-API-DMAC10.html) |
| CN (1) | CN116406373A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2021372975A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3196545A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL302471A (cg-RX-API-DMAC10.html) |
| MX (1) | MX2023005029A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2022098914A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20250005097A (ko) * | 2022-04-08 | 2025-01-09 | 페이트 세러퓨틱스, 인코포레이티드 | 고형 종양 표적화 골격을 갖는 세포 및 이의 용도 |
| KR20250004622A (ko) | 2022-04-08 | 2025-01-08 | 페이트 세러퓨틱스, 인코포레이티드 | 종양 표적화를 위한 키메라 항원 수용체 |
| CN116716342A (zh) * | 2022-06-22 | 2023-09-08 | 南京艾尔普再生医学科技有限公司 | 一种adcc功能增强的nk细胞的制作方法、nk细胞及其组合物 |
| JP2025522824A (ja) * | 2022-07-01 | 2025-07-17 | フェイト セラピューティクス,インコーポレイティド | 養子細胞療法におけるエフェクター細胞の耐久性及び有効性の増強 |
| AU2023315762A1 (en) * | 2022-07-25 | 2025-01-30 | Immunitybio, Inc. | Treatment of mhc-i negative tumors with nk and t cells |
| WO2024097800A1 (en) * | 2022-11-01 | 2024-05-10 | Fate Therapeutics, Inc. | Off-the-shelf therapeutic cells with multiplex genomic engineering for targeting kallikrein-2 |
| WO2024097901A1 (en) * | 2022-11-02 | 2024-05-10 | Fate Therapeutics, Inc. | Off-the-shelf therapeutic cells with multiplex genomic engineering for targeting cd79b |
| WO2025064822A2 (en) * | 2023-09-20 | 2025-03-27 | Factor Bioscience Inc. | Cells and methods for engineering cells with persistent transgene expression |
| CN118909951B (zh) * | 2024-07-05 | 2025-05-13 | 青岛华赛伯曼医学细胞生物有限公司 | 连续杀伤能力增强的工程化til细胞及其应用 |
| WO2026025087A1 (en) * | 2024-07-26 | 2026-01-29 | Dana-Farber Cancer Institute, Inc. | Nucleic acids and engineered cells for treating cancer |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2814846B1 (en) * | 2012-02-13 | 2020-01-08 | Seattle Children's Hospital d/b/a Seattle Children's Research Institute | Bispecific chimeric antigen receptors and therapeutic uses thereof |
| CN111556892A (zh) * | 2017-12-08 | 2020-08-18 | 菲特治疗公司 | 使用增强的iPSC衍生的效应细胞的免疫疗法 |
| BR112020011017A2 (pt) * | 2017-12-22 | 2020-11-17 | Fate Therapeutics, Inc. | células efetoras imunes intensificadas e uso das mesmas |
| EP3774866A1 (en) * | 2018-04-13 | 2021-02-17 | Ludwig Institute for Cancer Research Ltd | Heterodimeric inactivatable chimeric antigen receptors |
| EP4578507A3 (en) * | 2018-11-01 | 2025-11-12 | Gracell Biotechnologies (Shanghai) Co., Ltd. | Compositions and methods for t cell engineering |
| JP2022510207A (ja) * | 2018-12-02 | 2022-01-26 | フェイト セラピューティクス,インコーポレイテッド | 増強されたiPSC派生エフェクター細胞を使用した免疫療法 |
| CN113906133A (zh) * | 2019-04-11 | 2022-01-07 | 菲特治疗公司 | 工程改造的iPSC和免疫效应细胞中的CD3重建 |
| KR20250005097A (ko) * | 2022-04-08 | 2025-01-09 | 페이트 세러퓨틱스, 인코포레이티드 | 고형 종양 표적화 골격을 갖는 세포 및 이의 용도 |
-
2021
- 2021-11-04 WO PCT/US2021/058118 patent/WO2022098914A1/en not_active Ceased
- 2021-11-04 KR KR1020237018838A patent/KR20230098649A/ko active Pending
- 2021-11-04 CN CN202180074553.XA patent/CN116406373A/zh active Pending
- 2021-11-04 US US18/250,733 patent/US20230390337A1/en active Pending
- 2021-11-04 MX MX2023005029A patent/MX2023005029A/es unknown
- 2021-11-04 JP JP2023526068A patent/JP2023548467A/ja active Pending
- 2021-11-04 CA CA3196545A patent/CA3196545A1/en active Pending
- 2021-11-04 EP EP21890092.6A patent/EP4240831A4/en active Pending
- 2021-11-04 AU AU2021372975A patent/AU2021372975A1/en active Pending
- 2021-11-04 IL IL302471A patent/IL302471A/en unknown